Author Archives: pancreatica
Phase 2 Results of Gemcitabine and Monoclonal Antibody for Advanced Pancreatic Cancer
It’s hard to keep up with company changes in the biotech world, but a recent published study in the Annals of Oncology, the official journal of the European Society for Medical Oncology (ESMO) includes highly intriguing results of an unusual combination for advanced pancreatic cancer (ductal adenocarcinoma of the pancreas) of gemcitabine and the fully […]
Momordica Charantia (Bitter Melon) Juice Shows Promise with Pancreatic Cancer Cells and in Mice
Researchers from the University of California at San Diego have published a recent study in the journal Carcinogenesis that showed that Bitter Melon Juice (BMJ) caused cell death in four lines of pancreatic cancer cells, and appeared to inhibit pancreatic cancer tumor (ductal adenocarcinoma of the pancreas) activity in mice. The fruit of the vine […]
Phase 2 Results of Gemcitabine and Monoclonal Antibody for Advanced Pancreatic Cancer
It’s hard to keep up with company changes in the biotech world, but a recent published study in the Annals of Oncology, the official journal of the European Society for Medical Oncology (ESMO) includes highly intriguing results of an unusual combination for advanced pancreatic cancer (ductal adenocarcinoma of the pancreas) of gemcitabine and the fully […]
MicroRNA plus CA19-9 as a Diagnostic Marker for Pancreatic Cancer?
The search for a screening or diagnostic marker in pancreatic cancer (ductal adenocarcinoma of the pancreas) is paramount. If the disease could be found earlier, it is likely that serious inroads could be made into improved survival advantage for patients. Wang and associates at Fudan University in Shanghai, China published an intriguing article in April’s […]
More Abraxane in Combination with Gemcitabine for Pancreatic Cancer
Two studies have been published on April 1, 2013 about the efficacy of the combination drug regimen of nab-Paclitaxel (Abraxane) plus gemcitabine in the treatment of pancreatic cancer (ductal adenocarcinoma of the pancreas). These findings follow closely the earlier results of the international study of 861 patients with advanced pancreatic cancer who appeared to have […]